Literature DB >> 22586787

Intravenous diuretic day-care treatment for patients with heart failure.

P Banerjee1, G Tanner, L Williams.   

Abstract

Fluid overload is a common manifestation of decompensated chronic heart failure. This paper reports on a pilot study that investigated whether intravenous (i.v.) furosemide administered on a cardiology day ward for three successive days was effective in improving the symptoms of patients with fluid overload and chronic heart failure. The results showed that 94.1% of patients reported an improvement in their breathlessness, with a marked weight loss in 88.2% of patients. There were no marked changes in blood pressure or renal function. Hospital admission was avoided in 94.1% of cases. The study concluded that i.v. diuretic treatment given in a hospital day-care setting is safe and effective, and that it reduces the need for hospital admissions. As a consequence, this reduces the associated financial costs of hospitalisation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22586787      PMCID: PMC4954097          DOI: 10.7861/clinmedicine.12-2-133

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  6 in total

1.  Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.

Authors:  T P Dormans; J J van Meyel; P G Gerlag; Y Tan; F G Russel; P Smits
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

2.  Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.

Authors:  T P Dormans; P G Gerlag
Journal:  Eur Heart J       Date:  1996-12       Impact factor: 29.983

3.  Furosemide absorption altered in decompensated congestive heart failure.

Authors:  M R Vasko; D B Cartwright; J P Knochel; J V Nixon; D C Brater
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

4.  Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.

Authors:  Alan Maisel; Judd E Hollander; David Guss; Peter McCullough; Richard Nowak; Gary Green; Mitchell Saltzberg; Stefanie R Ellison; Meenakshi Awasthi Bhalla; Vikas Bhalla; Paul Clopton; Robert Jesse
Journal:  J Am Coll Cardiol       Date:  2004-09-15       Impact factor: 24.094

5.  Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure.

Authors:  Mary Ryder; Niamh F Murphy; Dermot McCaffrey; Christina O'Loughlin; Mark Ledwidge; Kenneth McDonald
Journal:  Eur J Heart Fail       Date:  2008-03-04       Impact factor: 15.534

6.  Metolazone in treatment of severe refractory congestive cardiac failure.

Authors:  A Kiyingi; M J Field; C C Pawsey; J Yiannikas; J R Lawrence; W J Arter
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

  6 in total
  4 in total

1.  Aerosol furosemide for dyspnea: Controlled delivery does not improve effectiveness.

Authors:  Capucine Morélot-Panzini; Carl R O'Donnell; Robert W Lansing; Richard M Schwartzstein; Robert B Banzett
Journal:  Respir Physiol Neurobiol       Date:  2017-10-12       Impact factor: 1.931

2.  The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settings.

Authors:  Kathryn Fitch; Jocelyn Lau; Tyler Engel; Joseph J Medicis; John F Mohr; William S Weintraub
Journal:  Clinicoecon Outcomes Res       Date:  2018-12-14

3.  OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST).

Authors:  Carine E Hamo; Sahar S Abdelmoneim; Seol Young Han; Elizabeth Chandy; Cornelia Muntean; Saadat A Khan; Prasanthi Sunkesula; Marcella Meykler; Vidhya Ramachandran; Emelie Rosenberg; Igor Klem; Terrence J Sacchi; John F Heitner
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

Review 4.  Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature.

Authors:  Eric Wierda; Cathelijne Dickhoff; Martin Louis Handoko; Liane Oosterom; Wouter Emmanuel Kok; Y de Rover; B A J M de Mol; Loek van Heerebeek; Jutta Maria Schroeder-Tanka
Journal:  ESC Heart Fail       Date:  2020-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.